3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.